Renal biopsy with 16G needle: A safety study

Guerrero-Ramos, F.; Villacampa-Aubá, F.; Jiménez-Alcaide, E.; García-González, L.; Ospina-Galeano, I.A.; Rosa-Kehrmann, Federico de la; Rodrı́guez-Antolı́n, A.; Passas-Martínez, J.B.; Díaz-González, Rafael

doi:10.1016/j.acuroe.2014.03.007

Cited by 3 publications

(1 citation statement)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…8 The safety of RMB has also been established, allowing its uptake. 8,9 Furthermore, studies of RMB for renal masses have also demonstrated good agreement between biopsy findings and surgical pathology for tumour histology, fair agreement for tumour grade, and limited risk of significant complications. 8 However some concerns remain in relation to diagnostic accuracy, with a relatively high proportion of false negatives in those identified as having benign tumours at biopsy (negative predictive value ~70%), and 10–20% of biopsies being non-diagnostic.…”

Section: Introductionmentioning

confidence: 97%

The role of renal mass biopsy in the management of small renal masses – patterns of use and surgeon opinion

Protani

Joshi

White

et al. 2020

Journal of Clinical Urology

View full text Add to dashboard Cite

Aims: Renal mass biopsy (RMB) is advocated to improve management of small renal masses, however there is concern about its clinical utility. This study aimed to elicit opinions about the role of RMB in small renal mass management from surgeons managing renal cell carcinomas (RCC), and examine the frequency of pre-treatment biopsy in those with RCC. Methods: All surgeons in two Australian states (Queensland: n = 59 and Victoria: n = 108) who performed nephrectomies for RCC in 2012/2013 were sent questionnaires to ascertain views about RMB. Response rates were 54% for Queensland surgeons and 38% for Victorian surgeons. We used medical records data from RCC patients to determine RMB frequency. Results: Most Queensland (81%) and Victorian (59%) surgeons indicated they rarely requested RMB; however 34% of Victorians reported often requesting RMB, compared with no Queensland surgeons. This was consistent with medical records data: 17.6% of Victorian patients with T1a tumours received RMB versus 6.7% of Queensland patients ( p < 0.001). Surgeons’ principal concerns regarding RMB related to sampling reliability (90%) and/or histopathological interpretation (76%). Conclusions: Most surgeons report infrequent use of RMB for small renal masses, however we observed practice variation. The principal reasons for infrequent use were concerns about sampling reliability and histopathological interpretation, which may be valid in regions with less access to interventional radiologists and uropathologists. Further evidence is required to define patient groups for whom biopsy results will alter management. Level of evidence: Not applicable for this multicentre audit.

show abstract

Section: Introductionmentioning

confidence: 97%

The role of renal mass biopsy in the management of small renal masses – patterns of use and surgeon opinion

Protani

Joshi

White

et al. 2020

Journal of Clinical Urology

View full text Add to dashboard Cite

show abstract

Evaluating renal biopsy-associated hemorrhage complications by the equation and providing an early intervention: a single-center experience

et al. 2015

View full text Add to dashboard Cite

show abstract

Ultrasound-guided percutaneous renal biopsy at a university hospital: retrospective analysis of success and complication rates

et al. 2021

View full text Add to dashboard Cite

Objective: To evaluate the success and complication rates of ultrasound-guided renal biopsy at a tertiary care hospital. Materials and Methods: This was a retrospective analysis of 97 ultrasound-guided renal biopsies, all performed by the same radiologist, between 1 March, 2017 and 31 October, 2019. Results: Of the 97 biopsies evaluated, 87 had a definitive pathological diagnosis. In five cases (5.4%), the biopsy results were inconclusive and a second procedure was required. In seven procedures (7.6%), there were complications, all of which were properly resolved. Conclusion: Ultrasound-guided renal biopsy has proven to be a safe, effective method for the diagnosis of nephropathies, with high success rates.

show abstract

Renal biopsy with 16G needle: A safety study

Cited by 3 publications

References 34 publications

The role of renal mass biopsy in the management of small renal masses – patterns of use and surgeon opinion

The role of renal mass biopsy in the management of small renal masses – patterns of use and surgeon opinion

Evaluating renal biopsy-associated hemorrhage complications by the equation and providing an early intervention: a single-center experience

Ultrasound-guided percutaneous renal biopsy at a university hospital: retrospective analysis of success and complication rates

Contact Info

Product

Resources

About